title: Lenalidomide is effective for extramedullary disease in relapsed or refractory multiple myeloma.
authors.forename: José M
authors.initials: JM
authors.lastname: Calvo-Villas
authors.forename: Adrián
authors.initials: A
authors.lastname: Alegre
authors.forename: Carmen
authors.initials: C
authors.lastname: Calle
authors.forename: Miguel T
authors.initials: MT
authors.lastname: Hernández
authors.forename: Ricarda
authors.initials: R
authors.lastname: García-Sánchez
authors.forename: Gema
authors.initials: G
authors.lastname: Ramírez
mesh_terms: D006801:Humans; D000077269:Lenalidomide; D009101:Multiple Myeloma / Q000188:drug therapy*; D016879:Salvage Therapy; D016019:Survival Analysis; D013792:Thalidomide / Q000031:analogs & derivatives* / Q000627:therapeutic use; D016896:Treatment Outcome
chemical_list: D013792:Thalidomide; D000077269:Lenalidomide